Showing results (91-100 of 160) with videos related to

Sort By:
Pageof 16
NMR in Biomedicine|March 25, 2011
A comparative study of dynamic contrast-enhanced MRI parameters as biomarkers for anti-angiogenic drug therapyTong San Koh, Choon Hua Thng, Septian Hartono, et al.
Lung Cancer (Amsterdam, Netherlands)|June 6, 2022
Efficacy and safety of lorlatinib in Asian and non-Asian patients with ALK-positive advanced non-small cell lung cancer: Subgroup analysis of a global phase 2 trialRoss A Soo, Eng Huat Tan, Hidetoshi Hayashi, et al.
BMC Genomics|December 19, 2014
Novel SNP improves differential survivability and mortality in non-small cell lung cancer patientsTzia Liang Mah, Xin Ning Adeline Yap, Vachiranee Limviphuvadh, et al.
Cancer Research|August 29, 2014
β-catenin contributes to lung tumor development induced by EGFR mutationsSohei Nakayama, Natasha Sng, Julian Carretero, et al.
Lung Cancer (Amsterdam, Netherlands)|June 10, 2008
Distribution of gemcitabine pathway genotypes in ethnic Asians and their association with outcome in non-small cell lung cancer patientsRoss A Soo, Ling Zhi Wang, Swee Siang Ng, et al.
EMBO Molecular Medicine|February 17, 2018
Fatty acid synthase mediates EGFR palmitoylation in EGFR mutated non-small cell lung cancerAzhar Ali, Elena Levantini, Jun Ting Teo, et al.
Lung Cancer (Amsterdam, Netherlands)|August 26, 2017
Validation of ALK/ROS1 Dual Break Apart FISH Probe probe in non-small-cell lung cancerSun Min Lim, Hyun Chang, Yoon Jin Cha, et al.
JTO Clinical and Research Reports|September 30, 2021
Serial Plasma Cell-Free Circulating Tumor DNA Tests Identify Genomic Alterations for Early Prediction of Osimertinib Treatment Outcome in EGFR T790M-Positive NSCLCBin-Chi Liao, Wei-Hsun Hsu, Jih-Hsiang Lee, et al.
Thoracic Cancer|September 30, 2022
Real-world experience of consolidation durvalumab after concurrent chemoradiotherapy in stage III non-small cell lung cancerYiqing Huang, Joseph J Zhao, Yu Yang Soon, et al.
Oncotarget|February 23, 2018
Determinants of variability of five programmed death ligand-1 immunohistochemistry assays in non-small cell lung cancer samplesRoss A Soo, Joey Sze Yun Lim, Bernadette Reyna Asuncion, et al.
Pageof 16